DES Safety in Bifurcation Lesions

Size: px
Start display at page:

Download "DES Safety in Bifurcation Lesions"

Transcription

1 DES Safety in Bifurcation Lesions Thierry Lefèvre On behalf of the ICPS Team

2 Safety Issues with 2 DES «cause of stent thrombosis stent underexpension, crush technique» Renu Virmani et al, TCT 2004

3 Safety Issues with Bifurcation Lesions? Iakovou et al. JAMA 2005;293: Ong et al. JACC 2005;45: Kuchulakanti et al. Circulation 2006;113:

4 SES (n = 1062), PES (n = 1167) Early and Late stent thrombosis Variables Hazard Ratio P value (95% CI) Premature antiplatelet ther. disc ( ).001 Renal failure 6.49 ( ).001 Bifurcation lesion 6.42 ( ).001 Diabetes 3.71 ( ).001 LVEF per 10% decrease 1.09 ( ).001 Iakovou et al. JAMA 2005;293:

5 Independent Predictors of Stent Thrombosis SES (n = 1062), PES (n = 1167) Late stent thrombosis Variables Hazard Ratio P Value (95% CI) Premature antiplatelet ther ( ).001 Bifurcation lesion 8.11 ( ).001 LVEF per 10% decrease 1.06 ( ).03 Iakovou et al. JAMA 2005;293:

6 Multivariate analysis Bifurcation OR 3.0, 95% CI , p< 0.01 Bifurcation + AMI OR 12.9, 95% CI , p< Ong et al JACC 2005;45:947 53

7 Ong et al JACC 2005;45:947 53

8 Ong et al JACC 2005;45:947 53

9 Kuchulakanti et al. Circulation 2006;113:

10 DES in Bifurcation Lesions: Safety % Stent Thrombosis

11 DES in Bifurcation Lesions: Safety % Stent Thrombosis

12 Can we Explain Safety Issues In Bifurcation Lesions?

13 1. Excess of Metal Finn et al ACC 2005

14 2. Fracture of the Polymer High Pressure (20 atm. 5x) Repeated Kissing Courtesy of J. Ormiston

15 3. Rheology not Optimal Asakura and Karino, Circulation Research 1990;66:1045-1

16 3. Rheology not Optimal

17 Case of a single stented coronary artery 8 Influence of thewireheightor impact rate on 2D flow perturbations Qualitative experimental results (Benard et al.) Qualitative and quantitative numerical results (Benard et al.) This study highlights that wire height is a preponderent factor of 2D flow perturbations

18 Macroscopic flow perturbations at stented bifurcation site A A B B B Physiological flow through a bifurcation model with palmaz stent (Fabregues, 1998, J. of Biomech.31) A: Stagnation zone appears if the stent does not conform to the artery. B: Stent implantation in the SB induces recirculation zones in the healthy artery branch

19 Crush Technique Stagnation area between the struts Delayed endothel. Recirculation Stent not apposed Courtesy of John Ormiston

20 Optimal Crush Stagnation area between the struts Delayed endothel. Recirculation Dr Hichiki

21 «Mini»Crush Recirculation Dr Hichiki

22 Culotte Technique Stent not apposed Stagnation area between the struts Delayed endothel. Recirculation Courtesy of John Ormiston

23 SKS Courtesy of John Ormiston

24 4. Stent Fracture

25 Popma, «Enter the DES Revolution», New Orleans 2007

26 Popma, «Enter the DES Revolution», New Orleans 2007

27 Popma, «Enter the DES Revolution», New Orleans 2007

28 Conclusion Bifurcation stenting is now a well known predictor of stent thrombosis at follow-up. When 2 stents are used, several factors may increase the risk (fractures, uncomplete stent apposition, delayed endothelialization, distorsion, recirculation...). Therefore a provisional side branch stenting approach is recommended.

29 Conclusion When 2 stents are needed, it is preferable to avoid long overlap of the 2 stents which is associated with a higher risk of stent or polymer fracture and poor Rheology. And always end with final kissing balloon inflation with correct balloon size.

EBC Rules of Bifurcation PCI

EBC Rules of Bifurcation PCI EBC Rules of Bifurcation PCI Y. Louvard, ICPS, Massy, France What is a coronary bifurcation? «Murray s law» Bifurcation branching laws D1 Murray s law D 3* 3* 3* 1 = D 2 + D 3 D3 Finet s law D 1 = 0.67(D

More information

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France 6 th European Bifurcation Club 22-23 October 2010 - BUDAPEST Kissing in simple strategy? Why and how I kiss Y. Louvard, ICPS, Massy France A long experience of kissing 1996 Patients 79 Final Kissing balloon

More information

I have nothing to disclose.

I have nothing to disclose. I have nothing to disclose. ESC congress of cardiology, 25-29th August 2012, Munich, Germany Minsk-Village 6, August 26 th, 2:22 PM Session: The grey zone of coronary interventions: The real bifurcation

More information

Bench Insights into Bifurcation Stenting in the DES Era: An Update

Bench Insights into Bifurcation Stenting in the DES Era: An Update Bench Insights into Bifurcation Stenting in the DES Era: An Update John Ormiston, Mark Webster, Peter Ruygrok, Jim Stewart, Douglas Scott, Duncan McNabb, Erin Currie, Monique Panther Mercy Hospital and

More information

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC Seoul, Korea: 25-27 27 April 2007 Session: Left mains & bifurcation intervention An integrated approach to bifurcation lesions: lessons from years of randomized

More information

Treatment of lesions at bifurcations: General perspective

Treatment of lesions at bifurcations: General perspective ESC Congress 2011 27-31 August, Paris, France Treatment of lesions at bifurcations: General perspective Goran Stankovic MD, PhD, FESC Division of Cardiology Clinical Center of Serbia, Belgrade Serbia Potential

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

Protection of side branch is essential in treating bifurcation lesions: overview

Protection of side branch is essential in treating bifurcation lesions: overview Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization

More information

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability

More information

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece The not so new development One vs. two stents General consensus In most bifurcational

More information

Y. Louvard, ICPS, Massy, France. TCT Asia Pacific 2010

Y. Louvard, ICPS, Massy, France. TCT Asia Pacific 2010 Provisional Bifurcation Stenting: Main Branch First Y. Louvard, ICPS, Massy, France TCT Asia Pacific 2010 No conflict of interest to declare M Main prox. first A Main Accross side first D Distal first

More information

Lessons for technique and stent choice

Lessons for technique and stent choice 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Session: What are the requirements for using a stent in a bifurcation? Lessons for technique and stent choice October 12 th : 16:45 17:50 Goran

More information

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations Innovative Devices : Non Stent Technologies : Drug Eluting Balloons A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations Pieter R. Stella, MD Director CardioVascular Research

More information

Stent Thrombosis in Bifurcation Stenting

Stent Thrombosis in Bifurcation Stenting Summit TCT Asia Pacific 2009 Stent Thrombosis in Bifurcation Stenting Associate Professor Tan Huay Cheem MBBS, M Med(Int Med), MRCP, FRCP(UK), FAMS, FACC, FSCAI Director, National University Heart Centre,

More information

Consensus so far and what we will be focusiong on this time

Consensus so far and what we will be focusiong on this time Consensus so far and what we will be focusiong on this time The 6 th European Bifurcation Club Meeting Budapest October 22-23 2010 Jens Flensted Lassen, MD, PH.D., FESC. Department of Cardiology B Skejby

More information

Contemporary therapy of bifurcation lesions

Contemporary therapy of bifurcation lesions Contemporary therapy of bifurcation lesions Dr Angela Hoye MB ChB PhD MRCP Interventional Cardiologist Kingston-upon-Hull, UK Hull The challenge of bifurcations Risk of peri-procedural infarction Relatively

More information

Drug Eluting Stents: an update Abbott Vascular. All rights reserved.

Drug Eluting Stents: an update Abbott Vascular. All rights reserved. Drug Eluting Stents: an update DES: Science and Education for Better Practice--Introduction The clinical benefits of DES in reducing the risk of restenosis are well established. Recently the safety profile

More information

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ DR ΝΙΚΟΛΑΟΣ ΚΑΥΚΑΣ MD, FESC Διευθυντής, Υπεύθυνος Αιμοδ/κού Εργαστηρίου Καρδιολογική Κλινική Γεν. Νοσοκομείο ΚΑΤ-ΕΚΑ PCI in Coronary Bifurcations Bifurcations

More information

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement

More information

Eulogio Garcia MD H. U. Gregorio Marañon Madrid

Eulogio Garcia MD H. U. Gregorio Marañon Madrid Eulogio Garcia MD H. U. Gregorio Marañon Madrid Coronary Bifurcation Lesions Open Issues Technically demanding Time consuming Low tech success rate Too much operator dependant Off-the the-shelf standard

More information

The 3 top Messages from technique Specific problems Solving

The 3 top Messages from technique Specific problems Solving The 3 top Messages from technique Specific problems Solving Alaide Chieffo Interventional Cardiology Unit San Raffaele Hospital Milan - Italy PROBLEMS DURING PROVISIONAL: SB PROTECTION AND RESCUE Francesco

More information

Seeing double: the double kissing crush stenting technique for coronary bifurcation lesions

Seeing double: the double kissing crush stenting technique for coronary bifurcation lesions xxxxxxx editorial Seeing double: the double kissing crush stenting technique for coronary bifurcation lesions In the drug-eluting stent era, interventionalists continue to face the traditional problems:

More information

Affiliation/Financial Relationship

Affiliation/Financial Relationship The Next ERA: COMBO Dual Therapy Stent The Unmet Need Roxana Mehran, MD Mount Sinai i School of Medicine i Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have

More information

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on

More information

Bench test : Is it still useful? Do we need standardization?

Bench test : Is it still useful? Do we need standardization? How to evaluate stents and techniques for bifurcation stenting? Bench test : Is it still useful? Do we need standardization? Yoshinobu Murasato MD, PhD Dept. of Cardiovascular Medicine, New Yukuhashi Hospital

More information

Modified Flower Petal Technique

Modified Flower Petal Technique JACC: CARDIOVASCULAR INTERVENTIONS VOL. 6, NO. 5, 2013 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2012.12.130

More information

DES In-stent Restenosis

DES In-stent Restenosis DES In-stent Restenosis Roxana Mehran, MD Columbia University Medical Center The Cardiovascular Research Foundation DES Restenosis Mechanisms Predictors Morphological patterns Therapy approach Mechanisms

More information

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis 11.45-12.07 Alaide Chieffo San Raffaele Scientific Institute, Milan, Italy Historical Perspective 25 20 15 10 5 0 Serruys 1991

More information

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi PCI for Bifurcations: Which is the best strategy DK Crush,Culotte,SKS,T or TAP Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi CSI 2018 Selection

More information

September Peter Barlis. Royal Brompton Hospital, London, UK

September Peter Barlis. Royal Brompton Hospital, London, UK 3rd EBC Meeting European Bifurcation Club September 2007 PALAU DE LA MUSICA, SalaRodrigo VALENCIA, SPAIN Culotte Technique in Left Main Disease Peter Barlis Carlo DiMario Royal Brompton Hospital, London,

More information

Drug eluting balloons in CAD

Drug eluting balloons in CAD Drug eluting balloons in CAD Ioannis Iakovou, MD, PhD Interventional Cardiology 1 st Cath Lab Onassis Cardiac Surgery Center Drug-Eluting Balloons (DEB) Technology and Applications 1. Special Features

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection Carlo Trani, MD, FESC Cardiology Department, Catholic University of the Sacred Heart, Rome - Italy How would you treat

More information

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Complex Coronary Interventions: Bifurcations John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Disclosures Advisory Board Boston Scientific, St. Jude Medical Speaker-

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Ruofei Jia, Zening Jin, Hong Li, Jing Han. Introduction

Ruofei Jia, Zening Jin, Hong Li, Jing Han. Introduction Case Report Re-crossing the distal cell in bifurcation verified by using an enhanced stent visualization system and optical coherence tomography: a report of two cases Ruofei Jia, Zening Jin, Hong Li,

More information

Insight from Nordic III

Insight from Nordic III Insight from Nordic III Fifth European Bifurcation Club Meeting Berlin 16-17 October 2009 Jens Flensted Lassen, MD, PH.D., FESC. Department of Cardiology Skejby Hospital, University of Aarhus Denmark Nordic-Baltic

More information

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries ANGIOPLASY SUMMIT 007 TCT ASIA PACIFIC Seoul, Korea: 5-7 7 April 007 15 min Plenary Session: State-of of-the-art Lectures The problem is exaggerated: Data from Real World Registries Antonio Colombo Centro

More information

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain) Provisional

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

Why I try to avoid side branch dilatation

Why I try to avoid side branch dilatation Why I try to avoid side branch dilatation Hyeon-Cheol Gwon Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Why I don t kiss? I kiss! I prefer to discuss SB ballooning rather

More information

Eberhard Grube MD FSCAI, FACC

Eberhard Grube MD FSCAI, FACC SCAI 30 th Annual Scientific Sessions Orlando/Fla BMS and DES Thrombosis Differences among DES Eberhard Grube MD FSCAI, FACC HELIOS Heart Center Siegburg, Siegburg, Germany Stanford University, School

More information

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore Unrelenting Left Main Disease in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore Clinical History 72 years old Chinese lady Background and CV Risk

More information

Béla MERKELY MD, PhD, DSc, FESC. Stent thrombosis: patophysiology, predisposing factors, definition, classification, prevention and treatment

Béla MERKELY MD, PhD, DSc, FESC. Stent thrombosis: patophysiology, predisposing factors, definition, classification, prevention and treatment Semmelweis University Heart Center Budapest, Hungary Béla MERKELY MD, PhD, DSc, FESC Stent thrombosis: patophysiology, predisposing factors, definition, classification, prevention and treatment 10th Interventional

More information

The jailed side branch and OCT guided cross over. Accidental abluminal rewiring, OCT check or optimal technique?

The jailed side branch and OCT guided cross over. Accidental abluminal rewiring, OCT check or optimal technique? Friday October 18th EBC 2013 FINAL PROGRAMME Morning 09:00-09:30 EBC board meeting 09:30-11:30 Abbott meeting with EBC Board 10:30-12:30 St Jude Medical pre-meeting 12:00 13:00 - WELCOME LUNCH PARALLEL

More information

Next Generation Drug- eluting Stent : Will It Solve the Problem?

Next Generation Drug- eluting Stent : Will It Solve the Problem? Next Generation Drug- eluting Stent : Will It Solve the Problem? Yangsoo Jang, M.D., Ph.D, FACC Severance Cardiovascular Hospital Yonsei University Healthcare System Commercially Available DES An Epidemic

More information

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot' OCT guided BVS for LMCA to LAD : Optimising the 'Pot' Dr Aniket Puri MD,DM,FRACP, FACC, FSCAI, FAPSIC Consultant Interventional Cardiologist Christchurch Hospital and Canterbury DHB(Univ of Otago) Christchurch,New

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study.

Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study. Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study. N. Boudou, N. Salvatella, N. Dumonteil, M.C. Morice, O. Darremont,

More information

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique . Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ". "Σύμπλοκη αγγειοπλαστική βλάβης διχασμού LAD/Diagonal (Medina 1,1,1) με την τεχνική DK crush ". Anastasios

More information

Antiplatelet Therapy After PCI: How Much and How Long?

Antiplatelet Therapy After PCI: How Much and How Long? Antiplatelet Therapy After PCI: How Much and How Long? Adnan Kastrati Deutsches Herzzentrum, Munich, GERMANY Antiplatelet Therapy after PCI: How much and how long? The simplest and extreme response: Give

More information

PCI for Bifurcation Coronary Lesion

PCI for Bifurcation Coronary Lesion PCI for Bifurcation Coronary Lesion Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43% Event Free Survival

More information

OCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial

OCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial OCT Optimised Bifurcation Event Reduction A Nordic Baltic British clinical outcome trial NIELS RAMSING HOLM, Skejby Denmark Study start: OCTOBER 2016 OCTOBER LMCA or non-lmca bifurcations with SB 2.5mm

More information

COMPLEX CASES: LEFT MAIN

COMPLEX CASES: LEFT MAIN COMPLEX CASES: LEFT MAIN Resolute Onyx DES Together are trademarks of Medtronic. * Third-party brands are trademarks of For distribution only in markets where the Resolute Onyx coronary stent has been

More information

Sunao Nakamura M.D,Ph.D.

Sunao Nakamura M.D,Ph.D. Drug Eluting Stent Implantation For Unprotected Left ain Coronary Arteries New Tokyo Circulation Research Group New Tokyo Hospital Sunao Nakamura.D,Ph.D. Drug-Eluting Stent for Left ain Coronary Artery

More information

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the

More information

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved. Stents selection and optimal implantation: sizes, design, deployment Stent classification: Mechanism of expansion - Self-expanding - Balloon expandable Design - Mesh structure - Coil - Slotted tube - Ring

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe?

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? T. Lefèvre,, Massy, France Background Despite continuous improvement, PTCA of chronic total occlusion remains a real technical challenge.

More information

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New York City Angioplasty

More information

Clinical Application of OCT in Stent Evaluation

Clinical Application of OCT in Stent Evaluation Imaging & Physiology Summit 2010 in Soul #1. Basics of Image Interpretation: IVUS/VH/OCT Clinical Application of OCT in Stent Evaluation Mitsuyasu Terashima, MD, PhD, FACC Stent implantation Stent Apposition

More information

Long-term freedom from angina and

Long-term freedom from angina and Hellenic J Cardiol 2010; 51: 368-373 Case Report The Crush Technique as a Therapeutic Approach for a Bifurcation Lesion in a Saphenous Venous Graft Io a n n i s Ka r a l i s, Ge o r g e Ko c h i a d a

More information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,

More information

DISCOVER Ultimaster with Optical Frequency Domain Imaging

DISCOVER Ultimaster with Optical Frequency Domain Imaging DISCOVER Ultimaster with Optical Frequency Domain Imaging David Hildick-Smith Sussex Cardiac Centre Brighton and Sussex University Hospitals United Kingdom Potential conflicts of interest Speaker's name:

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Non-LM bifurcation studies of importance in 2011

Non-LM bifurcation studies of importance in 2011 7th European Bifurcation Club 14-15 October 2011 LISBON Goran Stankovic MD, PhD Non-LM bifurcation studies of importance in 2011 October 15 th : 08:00 08:10 DKCRUSH-II: A Prospective Randomized Trial of

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis?

OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis? OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis? Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research

More information

What Stent to Use? JASVINDAR SINGH MD, FACC

What Stent to Use? JASVINDAR SINGH MD, FACC What Stent to Use? JASVINDAR SINGH MD, FACC ASSOCIATE PROFESSOR OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS DIRECTOR, CARDIAC CATHETERIZATION LAB BARNES-JEWISH HOSPITAL What Stent to Use? Jasvindar

More information

OCT Findings: Lesson from Stable vs Unstable Plaques

OCT Findings: Lesson from Stable vs Unstable Plaques ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston

More information

Stent Thrombosis: Patient, Procedural, and Stent Factors. Eugene Mc Fadden Cork, Ireland

Stent Thrombosis: Patient, Procedural, and Stent Factors. Eugene Mc Fadden Cork, Ireland Stent Thrombosis: Patient, Procedural, and Stent Factors Eugene Mc Fadden Cork, Ireland Definitions Early 1 yr TAXUS >6months CYPHER Incidence and Timing BMS Registry data

More information

PCI Update Qesaria 2009

PCI Update Qesaria 2009 PCI Update Qesaria 2009 Amit Segev Interventional Cardiology Chaim Outline Primary PCI Non-ST elevation ACS Multi-vessel disease Hemodynamic assessment of borderline lesions - FFR Stable AP Non-coronary

More information

Welcome to the 8 th European Bifurcation Club October Barcelona

Welcome to the 8 th European Bifurcation Club October Barcelona Welcome to the 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Safety and clinical efficacy of Sideguard stent for treatment of bifurcation lesions Interim results from European multicentre

More information

Drug eluting stents: Focus on Cypher sirolimuseluting coronary stents in the treatment of patients with bifurcation lesions

Drug eluting stents: Focus on Cypher sirolimuseluting coronary stents in the treatment of patients with bifurcation lesions REVIEW Drug eluting stents: Focus on Cypher sirolimuseluting coronary stents in the treatment of patients with bifurcation lesions Alaide Chieffo Tiziana Claudia Aranzulla Antonio Colombo Interventional

More information

Drug eluting stents From revolution to evolution. Current limitations

Drug eluting stents From revolution to evolution. Current limitations Drug eluting stents From revolution to evolution Current limitations Eric Eeckhout Centre Hospitalier Universitaire Vaudois Lausanne - Switzerland eric.eeckhout@chuv.ch Overview Historical perspective

More information

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 3, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 3, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 3, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2007.12.008 What Do

More information

Sites of Atherosclerosis In order of Frequency

Sites of Atherosclerosis In order of Frequency Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary

More information

The bioresorbable stent (BRS), or scaffold (as it

The bioresorbable stent (BRS), or scaffold (as it Understanding the Technical Aspects of Bioresorbable Stent Implantation The new Absorb polymer-based scaffold requires optimal implantation technique for best results. BY ASHOK SETH, FRCP, FACC, FSCAI,

More information

RESTENOSIS Facing up to the problem

RESTENOSIS Facing up to the problem RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis

More information

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,

More information

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent Masahiko Ochiai MD, FACC, FESC, FSCAI Division of Cardiology and Cardiovascular Surgery Showa University Northern Yokohama Hospital

More information

DES και θρόμβωση. Dimitrios Alexopoulos

DES και θρόμβωση. Dimitrios Alexopoulos DES και θρόμβωση Dimitrios Alexopoulos 30.10.2008 9 Prospective, Double-Blind, Randomized Trials Freedom From Ischemic TLR 100 RAVEL, SIRIUS, E-SIRIUS, C-SIRIUS (n=1,748) 100 TAXUS I, II, IV, V, VI (n=3,506)

More information

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Adjunct Professor Emory University School of Medicine Indication

More information

Treatment of Left Main Coronary Trifurcation Lesions with the Paclitaxel Drug-Eluting Stent: Mid-Term Outcomes from a Tertiary Medical Center

Treatment of Left Main Coronary Trifurcation Lesions with the Paclitaxel Drug-Eluting Stent: Mid-Term Outcomes from a Tertiary Medical Center Original Contribution Treatment of Left Main Coronary Trifurcation Lesions with the Paclitaxel Drug-Eluting Stent: Mid-Term Outcomes from a Tertiary Medical Center Nicolas W. Shammas, MD, MS, Gail A. Shammas,

More information

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts

More information

Non stent based intracoronary drug delivery

Non stent based intracoronary drug delivery Non stent based intracoronary drug delivery Dariusz Dudek Department of Interventional Cardiology Jagiellonian University, Krakow, Poland The European Association of Percutaneous Cardiovascular Interventions

More information

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI? TCT 2014 13 Sep 2014-17 Sep 2014, Washington, DC - U.S.A Will Bioresorbable Scaffolds Change How We Think About Left Main PCI? Robert-Jan van Geuns, MD, PhD Professor of Interventional Cardiology, Thoraxcenter,

More information

Insight from the CACTUS trial Coronary Bifurcation Application of the Crush

Insight from the CACTUS trial Coronary Bifurcation Application of the Crush EBC - Prague 26-28 september 2008 Insight from the CACTUS trial The role of final kissing balloon inflation F. Airoldi,, A. Colombo San Raffaele Scientific Institute EMO Centro Cuore,, Columbus Hospital

More information

DRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS

DRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS DRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS *Alessandro Durante, 1 Pietro Leonida Laforgia 2 1. Ospedale Valduce, Como, Italy 2. Università degli Studi di Milano, Milan, Italy *Correspondence

More information

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI HORIZONS-AMI: A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI Gregg W. Stone MD Columbia University Medical Center Cardiovascular Research Foundation Disclosures Gregg W. Stone

More information

Angiographic Stent Thrombosis at Coronary Bifurcations

Angiographic Stent Thrombosis at Coronary Bifurcations JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 1, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.09.015 Angiographic

More information

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.

More information

Pathology of Cardiovascular Interventions. Body and Disease 2011

Pathology of Cardiovascular Interventions. Body and Disease 2011 Pathology of Cardiovascular Interventions Body and Disease 2011 Coronary Artery Atherosclerosis Intervention Goals: Acute Coronary Syndromes: Treat plaque rupture and thrombosis Significant Disease: Prevent

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

INTRODUCTION. Catheterization and Cardiovascular Interventions 82:E871 E878 (2013)

INTRODUCTION. Catheterization and Cardiovascular Interventions 82:E871 E878 (2013) Catheterization and Cardiovascular Interventions 82:E871 E878 (2013) Two-Week Interval Optical Coherence Tomography: Imaging Evidence on Neointimal Coverage Completion After Implantation of the Endeavor

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

The Tryton Side Branch System in Distal Left Main PCI

The Tryton Side Branch System in Distal Left Main PCI The Tryton Side Branch System in Distal Left Main PCI Yaron Almagor, MD Director, Interventional Cardiology Shaare Zedek Medical Center Jerusalem, Israel TCTAP Seoul April 2013 Speaker s name: YARON ALMAGOR

More information

Catch-up Phenomenon: Insights from Pathology

Catch-up Phenomenon: Insights from Pathology Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re

More information

Lesions at coronary bifurcations represent a challenging

Lesions at coronary bifurcations represent a challenging Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions Antonio Colombo, MD; Jeffrey W. Moses, MD; Marie Claude Morice, MD; Josef Ludwig, MD; David R. Holmes, Jr,

More information

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion

More information